ALS and Neuromuscular disease center

Vall d'Hebron Hospital

Spain - Barcelona

Go to:

Location

119 Passeig de la Vall d’hebron, 08035,Barcelona,Spain

Neurologist, Head of Neuromuscular Disorders Unit

Closed for participation

In this study, an investigational oral drug named dazucorilant (also called CORT113176) is being studied in people living with ALS.

Archived

The CARDINALS clinical research study is evaluating a study drug (Utreloxastat) to see if it can help slow ALS symptoms.

Archived

In this phase 2 study, we are investigating the safety and efficacy of the drug pegcetacoplan for the treatment of ALS.

If you would like to contact us or register for a trial, leave your details here.